ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Repeat Kidney Transplantation from Living Donors Offers Comparable Outcomes as First Transplantation

N. Oh, K. Lee, J. Rhu, J. Kim, G. Choi, J. Park, J. Joh

Department of Surgery, Samsung Medical Center, Seoul, Korea, Republic of

Meeting: 2022 American Transplant Congress

Abstract number: 802

Keywords: Kidney transplantation, Retransplantation

Topic: Clinical Science » Kidney » 39 - Kidney Living Donor: Long Term Outcomes

Session Information

Session Name: Kidney Living Donor: Long Term Outcomes

Session Type: Poster Abstract

Date: Saturday, June 4, 2022

Session Time: 5:30pm-7:00pm

 Presentation Time: 5:30pm-7:00pm

Location: Hynes Halls C & D

*Purpose: The number of patients relisted for repeat kidney transplantation is increasing due to prolonged survival after first transplantation. This study is designed to compare the outcomes of second living donor kidney transplantation (LDKT) with first LDKT.

*Methods: Data were collected retrospectively for 1429 LDKT, performed from 1995 to 2020 at Samsung Medical Center. Demographic data of recipients and donors, immunologic factors, and outcomes of 2nd LDKT were compared to those of 1st LDKT.

*Results: Among 1429 cases of LDKT, 1355 were 1st LDKT, and 74 were 2nd LDKT. Basic demographic data were comparable for these two groups of patients.(Table 1) The 5- and 10-year graft survival of 1st LDKT were 94% and 84%, respectively, while those of 2nd LDKT were 96% and 86%, showing no significant differences (P = 0.399).(Figure 1) The 5-year patient survival of 1st LDKT was 98% and that of 2nd LDKT was 96%, while the respective 10-year survival was 94% and 93%, showing no significant differences (P = 0.766).(Figure 2) Multivariate analysis confirmed that history of previous transplantation was not a risk factor of graft survival (HR 0.83, P = 0.677) or patient survival (HR 1.68, P = 0.396).(Table 2&3)

*Conclusions: Therefore, repeat kidney transplantation with living donor is reasonable treatment of choice for patients experiencing graft loss.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Oh N, Lee K, Rhu J, Kim J, Choi G, Park J, Joh J. Repeat Kidney Transplantation from Living Donors Offers Comparable Outcomes as First Transplantation [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/repeat-kidney-transplantation-from-living-donors-offers-comparable-outcomes-as-first-transplantation/. Accessed May 8, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences